Danaher, Microsoft Partner on AI Platform for Scientific Instruments
By Kelly Cloonan
Danaher and Microsoft are teaming up to develop an agentic AI platform designed for scientific instruments and laboratories.
Danaher said Friday the partnership aims to help streamline experimental operations and speed up laboratory findings.
The platform will be built on Microsoft's AI technologies using Danaher's scientific, workflow and instrumentation expertise. It will aim to enable reuse and interoperability across technologies, so specialized products can be built on a shared foundation while remaining open to agents and digital solutions in multi-vendor laboratories, Danaher said.
Danaher said that while the platform is still under development, its first commercial AI applications--including an AI assistant designed to provide product support for cellular imaging systems--will reach its customers this year. Additional agent-enabled instruments from Danaher businesses that use the platform are planned for 2027, the company said.
"With Microsoft, we are building a common foundation, so our instruments and laboratories work together consistently, as one connected Danaher," said Julie Sawyer Montgomery, Danaher's president and chief executive.
Write to Kelly Cloonan at kelly.cloonan@wsj.com
(END) Dow Jones Newswires
November 20, 2026 08:15 ET (13:15 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular

5 Stocks to Buy After Earnings

The 10 Best Dividend Stocks

7 Undervalued Stocks That Crushed Earnings

The Best Balanced Funds and ETFs

